Projects

Development and validation of artificial intelligence tool for screening / detection of pulmonary TB and other lung diseases using chest X rays.

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2022 - 2024

Project Lead

Authors

Dr. Rashmi Rodrigues, Dr. Arun George, Dr. Chitra veluthat, Dr. Jovis Johny, Dr. Roja, Dr. Clyde,

Project Status

completed

Project Type

Funded by ICMR